Teladoc Health Balance Sheet Health

Financial Health criteria checks 4/6

Teladoc Health has a total shareholder equity of $2.3B and total debt of $1.5B, which brings its debt-to-equity ratio to 66.1%. Its total assets and total liabilities are $4.4B and $2.1B respectively.

Key information

66.1%

Debt to equity ratio

US$1.54b

Debt

Interest coverage ration/a
CashUS$1.12b
EquityUS$2.33b
Total liabilitiesUS$2.07b
Total assetsUS$4.39b

Recent financial health updates

Recent updates

Teladoc: Improving Business Trends (Rating Upgrade)

Apr 17

Teladoc: Management Has A Lot To Prove To Gain Investor Confidence

Mar 25

Teladoc Health, Inc.'s (NYSE:TDOC) 25% Dip In Price Shows Sentiment Is Matching Revenues

Mar 10
Teladoc Health, Inc.'s (NYSE:TDOC) 25% Dip In Price Shows Sentiment Is Matching Revenues

Teladoc Health: Another Bad Quarter, Another Wave Of Capitulation

Feb 21

Teladoc Health: Weight Management Rescue

Jan 21

Teladoc Health (NYSE:TDOC) Is Carrying A Fair Bit Of Debt

Jan 15
Teladoc Health (NYSE:TDOC) Is Carrying A Fair Bit Of Debt

When Should You Buy Teladoc Health, Inc. (NYSE:TDOC)?

Dec 12
When Should You Buy Teladoc Health, Inc. (NYSE:TDOC)?

Teladoc Q3: Getting Stronger (Rating Upgrade)

Nov 29

Teladoc Health, Inc.'s (NYSE:TDOC) Intrinsic Value Is Potentially 78% Above Its Share Price

Nov 22
Teladoc Health, Inc.'s (NYSE:TDOC) Intrinsic Value Is Potentially 78% Above Its Share Price

Teladoc Was Obliterated

Oct 25

Is Teladoc Health (NYSE:TDOC) A Risky Investment?

Oct 11
Is Teladoc Health (NYSE:TDOC) A Risky Investment?

Teladoc: Broken Growth Story Deteriorates Further (Rating Downgrade)

Oct 02

Teladoc Stock: A Hold Amid New Covid Wave

Sep 14

Teladoc's Technical Decline Hints At A Buying Opportunity

Aug 28

Is There An Opportunity With Teladoc Health, Inc.'s (NYSE:TDOC) 44% Undervaluation?

Aug 18
Is There An Opportunity With Teladoc Health, Inc.'s (NYSE:TDOC) 44% Undervaluation?

Buy Teladoc: AI Will Likely Spur Healthcare Deflation

Aug 16

Teladoc's Future: Virtual Healthcare, AI, And Valuation

Jul 28

Teladoc And Microsoft's Expanded Strategic Partnership Is A Powerful AI Combo

Jul 21

The Big Trends: New Frontiers in Healthcare

Jul 13
The Big Trends: New Frontiers in Healthcare

When Should You Buy Teladoc Health, Inc. (NYSE:TDOC)?

Jul 10
When Should You Buy Teladoc Health, Inc. (NYSE:TDOC)?

Teladoc Health: Likely To Remain Out Of Favor

Jun 26

Teladoc Health, Inc.'s (NYSE:TDOC) Revenues Are Not Doing Enough For Some Investors

Jun 25
Teladoc Health, Inc.'s (NYSE:TDOC) Revenues Are Not Doing Enough For Some Investors

Here's Why Teladoc Health (NYSE:TDOC) Can Afford Some Debt

May 25
Here's Why Teladoc Health (NYSE:TDOC) Can Afford Some Debt

Teladoc: BetterHelp Segment Margins Are Key

May 23

Are Investors Undervaluing Teladoc Health, Inc. (NYSE:TDOC) By 20%?

May 06
Are Investors Undervaluing Teladoc Health, Inc. (NYSE:TDOC) By 20%?

Is It Too Late To Consider Buying Teladoc Health, Inc. (NYSE:TDOC)?

Mar 10
Is It Too Late To Consider Buying Teladoc Health, Inc. (NYSE:TDOC)?

Teladoc Health Non-GAAP EPS of -$0.23 misses by $0.04, revenue of $637.7M beats by $4.33M

Feb 22

Is Teladoc Health (NYSE:TDOC) Using Too Much Debt?

Feb 01
Is Teladoc Health (NYSE:TDOC) Using Too Much Debt?

Teladoc's Stock Is Showing Signs Of Life

Jan 30

Teladoc: Unrealistic Assumptions Required To Buy

Jan 09

Teladoc: A Bargain If It Ever Reaches GAAP Profitability

Jan 02

An Intrinsic Calculation For Teladoc Health, Inc. (NYSE:TDOC) Suggests It's 45% Undervalued

Dec 23
An Intrinsic Calculation For Teladoc Health, Inc. (NYSE:TDOC) Suggests It's 45% Undervalued

Why did Teladoc Health stock fall today? Continued pressure for telehealth providers

Dec 22

Teladoc: Death By A Thousand Paper Cuts

Dec 17

What Is Teladoc Health, Inc.'s (NYSE:TDOC) Share Price Doing?

Nov 16
What Is Teladoc Health, Inc.'s (NYSE:TDOC) Share Price Doing?

Amazon Clinic seen putting pressure on telehealth providers Him & Hers Health, Teladoc

Nov 15

Teladoc Health GAAP EPS of -$0.45 beats by $0.12, revenue of $611.4M beats by $2.41M

Oct 26

Teladoc Health: Focus On Management Guidance And Takeover Potential

Oct 20

Teladoc: Cathie Wood Does It Again

Oct 11

Teladoc: The White Flag

Sep 27

Teladoc: Yes, Patient Investors Are Rewarded Again - Buy This Pullback

Sep 20

We Think Teladoc Health (NYSE:TDOC) Has A Fair Chunk Of Debt

Sep 18
We Think Teladoc Health (NYSE:TDOC) Has A Fair Chunk Of Debt

An Intrinsic Calculation For Teladoc Health, Inc. (NYSE:TDOC) Suggests It's 30% Undervalued

Aug 29
An Intrinsic Calculation For Teladoc Health, Inc. (NYSE:TDOC) Suggests It's 30% Undervalued

Amazon Out. World Of Teladoc Is Unfolding

Aug 25

Teladoc slips as Guggenheim hands first Sell rating

Aug 17

At US$37.79, Is It Time To Put Teladoc Health, Inc. (NYSE:TDOC) On Your Watch List?

Aug 11
At US$37.79, Is It Time To Put Teladoc Health, Inc. (NYSE:TDOC) On Your Watch List?

Teladoc: Don't Keep Buying Weak Execution And Disappointment

Aug 03

Financial Position Analysis

Short Term Liabilities: TDOC's short term assets ($1.5B) exceed its short term liabilities ($420.6M).

Long Term Liabilities: TDOC's short term assets ($1.5B) do not cover its long term liabilities ($1.6B).


Debt to Equity History and Analysis

Debt Level: TDOC's net debt to equity ratio (17.8%) is considered satisfactory.

Reducing Debt: TDOC's debt to equity ratio has increased from 40.9% to 66.1% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable TDOC has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: TDOC is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 40.7% per year.


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.